98 related articles for article (PubMed ID: 17113231)
1. Association of APOE with Parkinson disease age-at-onset in women.
Buchanan DD; Silburn PA; Prince JA; Mellick GD
Neurosci Lett; 2007 Jan; 411(3):185-8. PubMed ID: 17113231
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
3. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans].
Hao Y; Xie H; Xu L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703
[TBL] [Abstract][Full Text] [Related]
4. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
Feldman B; Chapman J; Korczyn AD
Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E
Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114
[TBL] [Abstract][Full Text] [Related]
7. Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology.
Ghebremedhin E; Del Tredici K; Vuksic M; Rüb U; Thal DR; Burbach GJ; Rosenberger A; Bickeböller H; Deller T; de Vos RA; Jansen Steur EN; Braak H
J Neuropathol Exp Neurol; 2006 Feb; 65(2):116-23. PubMed ID: 16462203
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A
Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828
[TBL] [Abstract][Full Text] [Related]
9. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ
Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
[TBL] [Abstract][Full Text] [Related]
11. Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?
Verbaan D; Boesveldt S; van Rooden SM; Visser M; Marinus J; Macedo MG; Fang Y; Heutink P; Berendse HW; van Hilten JJ
Neurology; 2008 Dec; 71(23):1877-82. PubMed ID: 19047559
[TBL] [Abstract][Full Text] [Related]
12. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.
Westberg L; Håkansson A; Melke J; Shahabi HN; Nilsson S; Buervenich S; Carmine A; Ahlberg J; Grundell MB; Schulhof B; Klingborg K; Holmberg B; Sydow O; Olson L; Johnels EB; Eriksson E; Nissbrandt H
Psychoneuroendocrinology; 2004 Sep; 29(8):993-8. PubMed ID: 15219649
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.
López M; Guerrero J; Yescas P; Boll MC; Familiar I; Ochoa A; Rasmussen A; Alonso ME
Mov Disord; 2007 Feb; 22(3):417-20. PubMed ID: 17230455
[TBL] [Abstract][Full Text] [Related]
14. The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women.
Lin JJ; Yueh KC; Chang CY; Chen CH; Lin SZ
Parkinsonism Relat Disord; 2004 Dec; 10(8):469-73. PubMed ID: 15542006
[TBL] [Abstract][Full Text] [Related]
15. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.
Tang G; Xie H; Xu L; Hao Y; Lin D; Ren D
Am J Med Genet; 2002 May; 114(4):446-9. PubMed ID: 11992569
[TBL] [Abstract][Full Text] [Related]
16. TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.
Peplonska B; Safranow K; Gaweda-Walerych K; Maruszak A; Czyzewski K; Rudzinska M; Barcikowska M; Zekanowski C
Neurobiol Aging; 2013 Aug; 34(8):2078.e1-2. PubMed ID: 23522842
[TBL] [Abstract][Full Text] [Related]
17. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
Lin JJ; Chen CH; Yueh KC; Chang CY; Lin SZ
Parkinsonism Relat Disord; 2006 Jan; 12(1):9-13. PubMed ID: 16337421
[TBL] [Abstract][Full Text] [Related]
18. The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study.
Vefring H; Haugarvoll K; Tysnes OB; Larsen JP; Kurz MW;
Acta Neurol Scand; 2010 Dec; 122(6):438-41. PubMed ID: 20456244
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
[TBL] [Abstract][Full Text] [Related]
20. Association between tau H2 haplotype and age at onset in frontotemporal dementia.
Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG
Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
